Favel L Mondesir

About Favel L Mondesir

I am an industry epidemiologist, originally from Saint Lucia, specializing in real-world…

Experience

1. Epidemiologist

   GSK

   Jan 2025 — Present

   Contribute to disease area strategy for COPD, including preparing communications material, and analyzing research evidence gaps involving data from external COPD cohorts.Deliver epidemiologic insights to inform drug development strategies, through codelist development and literature reviews for algorithms for potential adverse events among refractory and unexplained chronic cough clinical trial participants for a phase asset.Support Phase regulatory deliverables through background rate assessments, and literature reviews to inform on treatment patterns, comorbidities, and unmet needs across demographic and geographic subgroups for chronic rhinosinusitis with nasal polyps, and moderate to severe and type 2 asthma.Author protocols for rapid data query characterizing chronic rhinosinusitis with nasal polyps, and refractory chronic cough, using administrative claims data, to generate real world evidence in support of regulatory submissions and for internal decision making.Co-authored abstracts on the epidemiology of refractory/unexplained chronic coughEmploy the use of AI, including Undermind, for efficient literature searches.Manage a third-party vendor to facilitate delivery of multiple systematic literature reviews in support of a phase asset.

Education

• University of South Carolina

  Master of Science - MS

• South Carolina State University

  Bachelor of Science - BS (Summa Cum Laude)

• University of Alabama at Birmingham

  Doctor of Philosophy - PhD | American Heart Association Predoctoral Fellow